India's Piramal Pharma falls after US FDA observations at UK facility
15/09/2026 05:56
BUZZ-India's Piramal Pharma falls after US FDA observations at UK facility ** Shares of Piramal Pharma PIRM.NS fall 2.2% to 206.75 rupees
** Drugmaker says U.S. FDA issued seven observations following inspection of its Morpeth, UK facility
** All 10 analysts covering the stock rate it "buy", with 232.50 rupees as median PT - LSEG-compiled data
** Stock up 20.1% YTD
(Reporting by Payel Das in Bengaluru)
Recent news on Piramal Pharma (Mumbai)
See all newsBrief: Piramal Pharma (Mumbai) Says Commercial Arrangement With Bayer Pharmaceuticals To Expire On December 31, 2026
Brief: Piramal Pharma (Mumbai) Says Tax Authority Confirms Demand Of 40.6 Million Rupees And Imposes Equivalent Penalty
India's Piramal Pharma falls after US FDA observations at UK facility
Brief: Piramal Pharma Says US FDA Issues Form-483 With 7 Observations To Morpeth UK Facility
Brief: Piramal Pharma Approves Exercise Of Call Option For Acquisition Of Additional 41% Equity In Yapan Bio